Showing results (121-130 of 279) with videos related to
Sort By:
Pageof 28
Nutrition and Cancer|September 21, 2016
Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled TrialZhenzhen Zhang, Mark Garzotto, Tomasz M Beer, et al.Clinical Genitourinary Cancer|June 10, 2022
A Phase II, Single-arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell CarcinomaZizhen Feng, Brendan D Curti, David I Quinn, et al.Cancer|September 1, 2005
Recursive partitioning for risk stratification in men undergoing repeat prostate biopsiesMark Garzotto, Yon Park, Solange Mongoue-Tchokote, et al.Urologic Oncology|March 9, 2010
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory resultsRenee C Prins, Brooks L Rademacher, Solange Mongoue-Tchokote, et al.Archives of Physical Medicine and Rehabilitation|September 8, 2014
Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trialKerri M Winters-Stone, Jessica C Dobek, Jill A Bennett, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 15, 2012
Cell membrane water exchange effects in prostate DCE-MRIXin Li, Ryan A Priest, William J Woodward, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancerEthan M Basch, Mark R Somerfield, Tomasz M Beer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15Chung-Ying Huang, Tomasz M Beer, Celestia S Higano, et al.BJU International|September 11, 2008
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancerJoseph S Chan, Tomasz M Beer, David I Quinn, et al.Urology|May 25, 2010
Acupuncture for hot flashes in patients with prostate cancerTomasz M Beer, Maria Benavides, Sandra L Emmons, et al.Pageof 28